ROC analysis revealed that serum MEG3 discriminated healthy controls from BC with AUC = 0.92, 95% CI = 0.823–1.05, p < 0.0001, with sensitivity = 100%, specificity = 79.1%, and at a cutoff >0.43-fold. Here, MEG3 is linked to breast cancer.